Anpario (LON:ANP) Shares Up 10.9% – Still a Buy?

Shares of Anpario plc (LON:ANP) were up 10.9% during mid-day trading on Friday . The stock traded as high as GBX 415 ($5.11) and last traded at GBX 407.66 ($5.02). Approximately 152,837 shares were traded during trading, an increase of 273% from the average daily volume of 40,994 shares. The stock had previously closed at GBX 367.50 ($4.52).

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group lifted their price objective on shares of Anpario from GBX 340 ($4.18) to GBX 370 ($4.55) and gave the company a “buy” rating in a report on Wednesday, September 18th.

Anpario Trading Up 10.9 %

The company has a market capitalization of £68.94 million, a PE ratio of 2,264.78 and a beta of 0.58. The company has a debt-to-equity ratio of 0.21, a current ratio of 6.15 and a quick ratio of 5.16. The company’s fifty day moving average is GBX 355.75 and its 200-day moving average is GBX 319.41.

Insider Buying and Selling at Anpario

In other Anpario news, insider Karen Prior sold 14,000 shares of the firm’s stock in a transaction that occurred on Friday, December 13th. The shares were sold at an average price of GBX 380 ($4.68), for a total value of £53,200 ($65,460.81). 30.51% of the stock is owned by insiders.

About Anpario

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.